The study indicated that miR‐500a‐3p expression levels (Figure 3E) and HSC activation markers (α‐SMA, FAP, and vimentin) were gradually boosted in LX2 cells after treatment with HCC exosomes (Figure 3F). Here, VIM is linked to hepatocellular carcinoma.